Sangamo Therapeutics_SGMO Shrt Term LONG
The stock is still in early stage of the upward recovery trajectory and has managed to overcome its purple resistance level at $8.70. Mid-term resistance at $9.95 observed,while stronger resistance at $10.70.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.